Sedana Medical AB (publ) applies for registration of AnaConDa in Japan
Sedana Medical AB (”Sedana Medical” and “the Company”) has today submitted the application for registration of the medical device AnaConDa in Japan through its Japanese distributor.AnaConDa is a patented medical device with a unique technology making it possible to sedate patients with volatile anaesthetics in intensive care units, so called inhalation sedation. AnaConDa was approved by the South Korean authority K-FDA on February 23, 2017, the first country in Asia to do so. Sedana Medical has today applied to the Japanese authority, the Pharmaceutical and Medical Devices Agency, for the